Clinical Trials Browser

Active not recruiting × NSCLC × Chemoradiotherapy × Clear all

NCT06448910 2025-09-24

Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC

Phase 2 Active not recruiting

NSCLC